These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23171211)

  • 1. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial.
    See CW; Srinivasan M; Saravanan S; Oldenburg CE; Esterberg EJ; Ray KJ; Glaser TS; Tu EY; Zegans ME; McLeod SD; Acharya NR; Lietman TM
    Ophthalmic Epidemiol; 2012 Dec; 19(6):407-13. PubMed ID: 23171211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).
    Srinivasan M; Mascarenhas J; Rajaraman R; Ravindran M; Lalitha P; Glidden DV; Ray KJ; Hong KC; Oldenburg CE; Lee SM; Zegans ME; McLeod SD; Lietman TM; Acharya NR;
    Arch Ophthalmol; 2012 Feb; 130(2):143-50. PubMed ID: 21987582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial.
    Srinivasan M; Mascarenhas J; Rajaraman R; Ravindran M; Lalitha P; O'Brien KS; Glidden DV; Ray KJ; Oldenburg CE; Zegans ME; Whitcher JP; McLeod SD; Porco TC; Lietman TM; Acharya NR;
    Am J Ophthalmol; 2014 Feb; 157(2):327-333.e3. PubMed ID: 24315294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The steroids for corneal ulcers trial: study design and baseline characteristics.
    Srinivasan M; Mascarenhas J; Rajaraman R; Ravindran M; Lalitha P; Glidden DV; Ray KJ; Hong KC; Oldenburg CE; Lee SM; Zegans ME; McLeod SD; Lietman TM; Acharya NR;
    Arch Ophthalmol; 2012 Feb; 130(2):151-7. PubMed ID: 21987581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocardia keratitis: clinical course and effect of corticosteroids.
    Lalitha P; Srinivasan M; Rajaraman R; Ravindran M; Mascarenhas J; Priya JL; Sy A; Oldenburg CE; Ray KJ; Zegans ME; McLeod SD; Lietman TM; Acharya NR
    Am J Ophthalmol; 2012 Dec; 154(6):934-939.e1. PubMed ID: 22959881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment.
    Sy A; Srinivasan M; Mascarenhas J; Lalitha P; Rajaraman R; Ravindran M; Oldenburg CE; Ray KJ; Glidden D; Zegans ME; McLeod SD; Lietman TM; Acharya NR
    Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):267-72. PubMed ID: 22159005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual outcomes in treated bacterial keratitis: four years of prospective follow-up.
    McClintic SM; Prajna NV; Srinivasan M; Mascarenhas J; Lalitha P; Rajaraman R; Oldenburg CE; O'Brien KS; Ray KJ; Acharya NR; Lietman TM; Keenan JD
    Invest Ophthalmol Vis Sci; 2014 May; 55(5):2935-40. PubMed ID: 24618327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis.
    Oldenburg CE; Lalitha P; Srinivasan M; Manikandan P; Bharathi MJ; Rajaraman R; Ravindran M; Mascarenhas J; Nardone N; Ray KJ; Glidden DV; Acharya NR; Lietman TM
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1522-6. PubMed ID: 23385795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India.
    Oldenburg CE; Lalitha P; Srinivasan M; Rajaraman R; Ravindran M; Mascarenhas J; Borkar DS; Ray KJ; Zegans ME; McLeod SD; Porco TC; Lietman TM; Acharya NR
    Ophthalmic Epidemiol; 2013 Jun; 20(3):155-8. PubMed ID: 23662986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early addition of topical corticosteroids in the treatment of bacterial keratitis.
    Ray KJ; Srinivasan M; Mascarenhas J; Rajaraman R; Ravindran M; Glidden DV; Oldenburg CE; Sun CQ; Zegans ME; McLeod SD; Acharya NR; Lietman TM
    JAMA Ophthalmol; 2014 Jun; 132(6):737-41. PubMed ID: 24763755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in corneal scarring following bacterial keratitis.
    McClintic SM; Srinivasan M; Mascarenhas J; Greninger DA; Acharya NR; Lietman TM; Keenan JD
    Eye (Lond); 2013 Mar; 27(3):443-6. PubMed ID: 23238443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis.
    Borkar DS; Fleiszig SM; Leong C; Lalitha P; Srinivasan M; Ghanekar AA; Tam C; Li WY; Zegans ME; McLeod SD; Lietman TM; Acharya NR
    JAMA Ophthalmol; 2013 Feb; 131(2):147-53. PubMed ID: 23411878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual recovery in treated bacterial keratitis.
    Srinivasan M; Mascarenhas J; Rajaraman R; Ravindran M; Lalitha P; Ray KJ; Zegans ME; Acharya NR; Lietman TM; Keenan JD;
    Ophthalmology; 2014 Jun; 121(6):1310-1. PubMed ID: 24612976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis.
    Ray KJ; Prajna L; Srinivasan M; Geetha M; Karpagam R; Glidden D; Oldenburg CE; Sun CQ; McLeod SD; Acharya NR; Lietman TM
    JAMA Ophthalmol; 2013 Mar; 131(3):310-3. PubMed ID: 23307105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroids for bacterial corneal ulcers.
    Srinivasan M; Lalitha P; Mahalakshmi R; Prajna NV; Mascarenhas J; Chidambaram JD; Lee S; Hong KC; Zegans M; Glidden DV; McLeod S; Whitcher JP; Lietman TM; Acharya NR
    Br J Ophthalmol; 2009 Feb; 93(2):198-202. PubMed ID: 18829631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial.
    Sharma N; Goel M; Bansal S; Agarwal P; Titiyal JS; Upadhyaya AD; Vajpayee RB
    Ophthalmology; 2013 Jun; 120(6):1173-8. PubMed ID: 23415776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis.
    Lalitha P; Srinivasan M; Manikandan P; Bharathi MJ; Rajaraman R; Ravindran M; Cevallos V; Oldenburg CE; Ray KJ; Toutain-Kidd CM; Glidden DV; Zegans ME; McLeod SD; Acharya NR; Lietman TM
    Clin Infect Dis; 2012 May; 54(10):1381-7. PubMed ID: 22447793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does in vitro susceptibility predict clinical outcome in bacterial keratitis?
    Chen A; Prajna L; Srinivasan M; Mahalakshmi R; Whitcher JP; McLeod S; Lietman TM; Acharya NR
    Am J Ophthalmol; 2008 Mar; 145(3):409-412. PubMed ID: 18207124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moxifloxacin for bacterial keratitis.
    Rosenberg J; Eisen L; Kim J
    Ophthalmology; 2008 Jun; 115(6):1103; author reply 1103. PubMed ID: 18519075
    [No Abstract]   [Full Text] [Related]  

  • 20. Subgroup analysis in the steroids for corneal ulcers trial.
    Dulku S
    Arch Ophthalmol; 2012 Jun; 130(6):807-8; author reply 808. PubMed ID: 22801856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.